Stephanie M Perkins

Dr. Stephanie M Perkins


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in British Journal of Radiology
Verified
Journal Article
Closed access
MLMiranda P. Lawell
Miranda P. Lawell
DIDaniel J Indelicato
Daniel J Indelicato
APArnold C. Paulino
Arnold C. Paulino
WHWilliam Hartsell
William Hartsell
NLNadia Laack
Nadia Laack
TYTorunn I. Yock
Torunn I. Yock
Objective: The Pediatric Proton/Photon Consortium Registry (PPCR) is a comprehensive data registry composed of pediatric patients treated with radiation. It was established to expedite outcomes-based research. The attributes which allow the PPCR to be a successful collaboration are reviewed. Methods and materials: Current eligibility criteria are radiotherapy patients < 22 years treated at one of the 15 US participating institutions. Detailed health and treatment data are collected about the disease presentation and treatment exposures, and annually thereafter, in REDCap (Research Electronic Data Capture). DICOM (Digital Imaging and Communications in Medicine) imaging and radiation plans are collected through MIM/MIMcloud. An optional patient-reported quality-of-life (PedsQL) study is administered at 10 sites. Results: Accrual started October 2012 with 2,775 participants enrolled as of 25 July 2019. Most patients, 62.0%, were treated for central nervous system (CNS) tumors, the most common of which are medulloblastoma (n = 349), ependymoma (n = 309), and glial/astrocytoma tumors (n = 279). The most common non-CNS diagnoses are rhabdomyosarcoma (n = 284), Ewing’s sarcoma (n = 153), and neuroblastoma (n = 130). While the majority of participants are US residents, 18.7% come from 36 other countries. Over 685 patients participate in the PedsQL study. Conclusions: The PPCR is a valuable research platform capable of answering countless research questions that will ultimately improve patient care. Centers outside of the USA are invited to participate directly or may engage with the PPCR to align data collection strategies to facilitate large-scale international research. Advances in knowledge: For investigators looking to carry out research in a large pediatric oncology cohort or interested in registry work, this paper provides an updated overview of the PPCR.

1 April 2019 in Advances in Radiation Oncology
Verified
Journal Article
Open access
LHLauren E. Henke
Lauren E. Henke
OGOlga L. Green
Olga L. Green
JSJoshua Schiff
Joshua Schiff
VRVivian L. Rodriguez
Vivian L. Rodriguez
SMSasa Mutic
Sasa Mutic
SPStephanie M Perkins
Stephanie M Perkins

1 July 2020 in Practical Radiation Oncology
Verified
Journal Article
Closed access
JBJustin M. Barnes
Justin M. Barnes
ASAmar J. Srivastava
Amar J. Srivastava
PGPrashant Gabani
Prashant Gabani
SPStephanie M Perkins
Stephanie M Perkins

11 September 2023 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
BSBenjamin A. Seitzman
Benjamin A. Seitzman
HAHari Anandarajah
Hari Anandarajah
ADAlly Dworetsky
Ally Dworetsky
AMAlana McMichael
Alana McMichael
RCRebecca S. Coalson
Rebecca S. Coalson
SPStephanie M Perkins
Stephanie M Perkins

25 September 2023 in GeroScience
Verified
Journal Article
Open access
PDF file
BSBenjamin A. Seitzman
Benjamin A. Seitzman
FRFrancisco J. Reynoso
Francisco J. Reynoso
TMTimothy J. Mitchell
Timothy J. Mitchell
ABAnnie R. Bice
Annie R. Bice
AJAnmol Jarang
Anmol Jarang
ABAdam Q. Bauer
Adam Q. Bauer
Cognitive dysfunction following radiotherapy (RT) is one of the most common complications associated with RT delivered to the brain, but the precise mechanisms behind this dysfunction are not well understood, and to date, there are no preventative measures or effective treatments. To improve patient outcomes, a better understanding of the effects of radiation on the brain’s functional systems is required. Functional magnetic resonance imaging (fMRI) has shown promise in this regard, however, compared to neural activity, hemodynamic measures of brain function are slow and indirect. Understanding how RT acutely and chronically affects functional brain organization requires more direct examination of temporally evolving neural dynamics as they relate to cerebral hemodynamics for bridging with human studies. In order to adequately study the underlying mechanisms of RT-induced cognitive dysfunction, the development of clinically mimetic RT protocols in animal models is needed. To address these challenges, we developed a fractionated whole-brain RT protocol (3Gy/day for 10 days) and applied longitudinal wide field optical imaging (WFOI) of neural and hemodynamic brain activity at 1, 2, and 3 months post RT. At each time point, mice were subject to repeated behavioral testing across a variety of sensorimotor and cognitive domains. Disruptions in cortical neuronal and hemodynamic activity observed 1 month post RT were significantly worsened by 3 months. While broad changes were observed in functional brain organization post RT, brain regions most impacted by RT occurred within those overlapping with the mouse default mode network and other association areas similar to prior reports in human subjects. Further, significant cognitive deficits were observed following tests of novel object investigation and responses to auditory and contextual cues after fear conditioning. Our results fill a much-needed gap in understanding the effects of whole-brain RT on systems level brain organization and how RT affects neuronal versus hemodynamic signaling in the cortex. Having established a clinically-relevant injury model, future studies can examine therapeutic interventions designed to reduce neuroinflammation-based injury following RT. Given the overlap of sequelae that occur following RT with and without chemotherapy, these tools can also be easily incorporated to examine chemotherapy-related cognitive impairment.

25 July 2023 in International Journal of Particle Therapy
Verified
Journal Article
Open access
PDF file
ADAnna V. Dowling
Anna V. Dowling
BSBenjamin A. Seitzman
Benjamin A. Seitzman
TMTimothy J. Mitchell
Timothy J. Mitchell
MOMichael Olufawo
Michael Olufawo
DDDonna L. Dierker
Donna L. Dierker
SPStephanie M Perkins
Stephanie M Perkins
Purpose. Pediatric brain tumor patients often experience significant cognitive sequelae. Resting-state functional MRI (rsfMRI) provides a measure of brain network organization, and we hypothesize that pediatric brain tumor patients treated with proton therapy will demonstrate abnormal brain network architecture related to cognitive outcome and radiation dosimetry.Participants and Methods. Pediatric brain tumor patients treated with proton therapy were enrolled on a prospective study of cognitive assessment using the NIH Toolbox Cognitive Domain. rsfMRI was obtained in participants able to complete unsedated MRI. Brain system segregation (BSS), a measure of brain network architecture, was calculated for the whole brain, the high-level cognition association systems, and the sensory-motor systems.Results. Twenty-six participants were enrolled in the study for cognitive assessment, and 18 completed rsfMRI. There were baseline cognitive deficits in attention and inhibition and processing speed prior to radiation with worsening performance over time in multiple domains. Average BSS across the whole brain was significantly decreased in participants compared with healthy controls (1.089 and 1.101, respectively; P = 0.001). Average segregation of association systems was significantly lower in participants than in controls (P < 0.001) while there was no difference in the sensory motor networks (P = 0.70). Right hippocampus dose was associated with worse attention and inhibition (P < 0.05) and decreased segregation in the dorsal attention network (P < 0.05).Conclusion. Higher mean dose to the right hippocampus correlated with worse dorsal attention network segregation and worse attention and inhibition cognitive performance. Patients demonstrated alterations in brain network organization of association systems measured with rsfMRI; however, somatosensory system segregation was no different from healthy children. Further work with preradiation rsfMRI is needed to assess the effects of surgery and presence of a tumor on brain network architecture.